Tags

Type your tag names separated by a space and hit enter

[Effects of renin-angiotensin system blockers on left ventricular hypertrophy and biochemical markers of collagen balance in patients with hypertensive hypertrophy].
Ter Arkh. 2009; 81(5):64-71.TA

Abstract

AIM

To evaluate the effect of ACE inhibitor enalapril, AR blocker candesartan and their combination on left ventricular hypertrophy (LVH) and content of biochemical markers of collagen balance in patients with hypertensive LV hypertrophy. MATERIAL AND METHODS. A total of 66 patients with arterial hypertension with LV hypertrophy were divided into two groups. Group 1 (n = 33) received candesartan (8-16 mg/day), group 2 (n = 33) received enalapril (10-20 mg/day). In effective hypotensive response to the initial treatment, it was continued for 6 months. If in two months of monotherapy the effect was unsatisfactory, the other drug was added. At baseline and upon 6 months of treatment all the patients were examined for myocardial mass index (MMI), matrix metalloproteinase-1 (MMP-1) and tissue inhibitor of matrix metalloproteinase-1 (THMP-1) in the blood.

RESULTS

In effective initial treatment with candesartan 6-month treatment lowered LV MMI by 13.9%, while in enalapril group--only by 1.5%. In addition of the second drug in ineffective initial therapy the reduction was 5.1%. THMP-1 did not change during the trial.

CONCLUSION

In patients with hypertensive LVH candesartan more effectively treated LVH. The addition of the second RAS blocker in insufficient efficacy of the initial one significantly reduces LV MMI. A significant antifibrotic effect was achieved only in case of simultaneous use of two RAS blockers.

Authors

No affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Clinical Trial
English Abstract
Journal Article

Language

rus

PubMed ID

19537590

Citation

Ovchinnikov, A G., et al. "[Effects of Renin-angiotensin System Blockers On Left Ventricular Hypertrophy and Biochemical Markers of Collagen Balance in Patients With Hypertensive Hypertrophy]." Terapevticheskii Arkhiv, vol. 81, no. 5, 2009, pp. 64-71.
Ovchinnikov AG, Serbul VM, Ageev FT. [Effects of renin-angiotensin system blockers on left ventricular hypertrophy and biochemical markers of collagen balance in patients with hypertensive hypertrophy]. Ter Arkh. 2009;81(5):64-71.
Ovchinnikov, A. G., Serbul, V. M., & Ageev, F. T. (2009). [Effects of renin-angiotensin system blockers on left ventricular hypertrophy and biochemical markers of collagen balance in patients with hypertensive hypertrophy]. Terapevticheskii Arkhiv, 81(5), 64-71.
Ovchinnikov AG, Serbul VM, Ageev FT. [Effects of Renin-angiotensin System Blockers On Left Ventricular Hypertrophy and Biochemical Markers of Collagen Balance in Patients With Hypertensive Hypertrophy]. Ter Arkh. 2009;81(5):64-71. PubMed PMID: 19537590.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Effects of renin-angiotensin system blockers on left ventricular hypertrophy and biochemical markers of collagen balance in patients with hypertensive hypertrophy]. AU - Ovchinnikov,A G, AU - Serbul,V M, AU - Ageev,F T, PY - 2009/6/23/entrez PY - 2009/6/23/pubmed PY - 2009/9/15/medline SP - 64 EP - 71 JF - Terapevticheskii arkhiv JO - Ter Arkh VL - 81 IS - 5 N2 - AIM: To evaluate the effect of ACE inhibitor enalapril, AR blocker candesartan and their combination on left ventricular hypertrophy (LVH) and content of biochemical markers of collagen balance in patients with hypertensive LV hypertrophy. MATERIAL AND METHODS. A total of 66 patients with arterial hypertension with LV hypertrophy were divided into two groups. Group 1 (n = 33) received candesartan (8-16 mg/day), group 2 (n = 33) received enalapril (10-20 mg/day). In effective hypotensive response to the initial treatment, it was continued for 6 months. If in two months of monotherapy the effect was unsatisfactory, the other drug was added. At baseline and upon 6 months of treatment all the patients were examined for myocardial mass index (MMI), matrix metalloproteinase-1 (MMP-1) and tissue inhibitor of matrix metalloproteinase-1 (THMP-1) in the blood. RESULTS: In effective initial treatment with candesartan 6-month treatment lowered LV MMI by 13.9%, while in enalapril group--only by 1.5%. In addition of the second drug in ineffective initial therapy the reduction was 5.1%. THMP-1 did not change during the trial. CONCLUSION: In patients with hypertensive LVH candesartan more effectively treated LVH. The addition of the second RAS blocker in insufficient efficacy of the initial one significantly reduces LV MMI. A significant antifibrotic effect was achieved only in case of simultaneous use of two RAS blockers. SN - 0040-3660 UR - https://www.unboundmedicine.com/medline/citation/19537590/[Effects_of_renin_angiotensin_system_blockers_on_left_ventricular_hypertrophy_and_biochemical_markers_of_collagen_balance_in_patients_with_hypertensive_hypertrophy]_ L2 - https://medlineplus.gov/highbloodpressure.html DB - PRIME DP - Unbound Medicine ER -